Articles about Russian Direct Investment Fund

13 Jul 2021
IndiaThe Serum Institute of India (SII) will begin producing the Russian COVID-19 vaccine, Sputnik V, from September, the Russian Direct Investment Fund (RDIF) announced today.

06 Jul 2021
IndiaMorepen Laboratories has started production of the test batch of Russia's Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, the Russian Direct Investment Fund (RDIF) and the drug firm said in a statement on Tuesday.

13 Apr 2021
IndiaSputnik V, the Russia-made coronavirus vaccine, will be manufactured in India by five pharmaceutical firms. It is estimated that 850 million doses will be produced yearly.

19 Mar 2021
WorldStelis Biopharma, the biopharmaceutical arm of Bengaluru-based Strides Pharma Science, will be making and supplying at least 200 million doses of the Sputnik V vaccine, the Russian coronavirus vaccine currently awaiting emergency use approval in India.

22 Dec 2020
WorldDevelopers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.

18 Dec 2020
TechnologyIndia will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.

02 Dec 2020
WorldRussian President Vladimir Putin on Wednesday ordered authorities to start mass voluntary vaccinations for COVID-19.

27 Nov 2020
TechnologyIndia will produce over 100 million doses a year of the Russian COVID-19 vaccine Sputnik V starting 2021, under an agreement between the Russian Direct Investment Fund (RDIF) and Hyderabad-based Hetero Biopharma, Hindustan Times reported.

24 Nov 2020
TechnologyThe Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.

22 Nov 2020
TechnologyRussia's COVID-19 vaccine candidate, called Sputnik V, is expected to start human trials in India soon.

25 Oct 2020
IndiaPhase II clinical trials for the Russian COVID-19 vaccine, Sputnik V, will have 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) has told Sputnik.

08 Oct 2020
IndiaIndia's drug regulator has refused to allow a large scale clinical trial of Russia's Sputnik V COVID-19 vaccine.

18 Sep 2020
TechnologySputnik V, the COVID-19 vaccine developed and approved by Russia, has shown side effects in some trial volunteers.

16 Sep 2020
IndiaIn a major development, Hyderabad-based pharma company Dr. Reddy's Laboratories has partnered with the Russian Direct Investment Fund (RDIF) to source their Sputnik V COVID-19 vaccine for India.

21 Aug 2020
WorldRussia has been in the headlines for its two-month-tested 'Sputnik V' COVID-19 vaccine.

09 Aug 2020
WorldRussian health officials are set to register a vaccine candidate for the novel coronavirus disease, COVID-19, as early as this week.